KPWS
CODX

Kestra Private Wealth Services’s Co-Diagnostics CODX Stock Holding History

Kestra Private Wealth Services’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-343
Closed -$100K – 811
2020
Q4 		$100K Hold
343
– – 0.01% 707
2020
Q3 		$140K Buy
+343
New +$176K 0.01% 626

Other funds holding CODX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Kestra Private Wealth Services's CODX Position: Q1 2021 in Review

Kestra Private Wealth Services sold out of Co-Diagnostics (CODX) in Q1 2021, closing a stake of 343 shares — an estimated $100K sold.

Kestra Private Wealth Services first reported a position in CODX in Q3 2020 and held it in 2 quarters. The position peaked at $140K in Q3 2020. 95 funds tracked by Wall St. Rank hold CODX as of Q1 2021.

  • Kestra Private Wealth Services reported no remaining Co-Diagnostics position as of Q1 2021 after selling out during the quarter.
  • Kestra Private Wealth Services sold 343 Co-Diagnostics shares in Q1 2021, an estimated $100K.
  • Kestra Private Wealth Services first reported a position in Co-Diagnostics in Q3 2020 and held it in 2 quarters.
  • Kestra Private Wealth Services's Co-Diagnostics position peaked at $140K in Q3 2020.
  • 95 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2021.

Based on Kestra Private Wealth Services's 13F filing for Q1 2021, filed 11 May 2021.